| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/10/2001 | WO2000061635A3 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 05/10/2001 | WO2000057923A3 Radioactive seed with multiple markers and method for using same |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389849A1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1096955A2 Cancer treatment methods using antibodies to aminophospholipids |
| 05/08/2001 | US6228605 Detection of helicobacter pylori in the stomach |
| 05/08/2001 | US6228362 Boron neutron capture therapy using pre-targeting methods |
| 05/08/2001 | CA2239018C Measurement of gastric emptying |
| 05/03/2001 | WO2001031334A1 Method and means for detecting inflammatory processes |
| 05/03/2001 | WO2001031015A2 36p6d5: secreted tumor antigen |
| 05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 05/03/2001 | WO2001013893A3 Use of simple amino acids to form porous particles |
| 05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 05/03/2001 | US20010000785 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 05/03/2001 | CA2388100A1 Method and means for detecting inflammatory processes |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1094840A1 Use of texaphyrins in macrophage-mediated disease |
| 05/02/2001 | CN1293067A Use of 4-(4-ethoxybenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/02/2001 | CN1293036A Use of 4-(4-ethoxygenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | US6224880 Vaccines |
| 05/01/2001 | US6224849 Alkylaminobenzothiazole and-benzoxazole derivatives |
| 05/01/2001 | US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom |
| 05/01/2001 | US6224536 Method for delivering radiation therapy to an intravascular site in a body |
| 05/01/2001 | CA2195395C Cyclic hexapeptide somatostatin analogues |
| 05/01/2001 | CA2167807C Radiolabeled glucans |
| 05/01/2001 | CA2037299C Gamma emitting, cck-a antagonists for pancreatic imaging |
| 04/26/2001 | WO2001028595A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | WO2001028592A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | CA2387925A1 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
| 04/26/2001 | CA2387767A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | CA2387757A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/25/2001 | EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses |
| 04/24/2001 | US6221334 Polyaza macrocyclic ligands chelated to superparamagnetic or paramagnetic metals and coupled to folate-receptor binding ligands through the gamma carboxylate of folate |
| 04/24/2001 | CA2239111C Measurement of liquid phase gastric emptying |
| 04/24/2001 | CA2111863C Technetium-99m labeled peptides for imaging |
| 04/22/2001 | WO2002102250A1 $g(in vivo) imaging |
| 04/22/2001 | CA2422767A1 In vivo imaging |
| 04/19/2001 | WO2001027159A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 04/19/2001 | WO2001026695A1 Methods and apparatus for characterizing lesions in blood vessels and other body lumens |
| 04/18/2001 | EP1092726A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses |
| 04/18/2001 | EP1092723A2 Bisphosphonic acid derivative and compound thereof labelled with radioactive nuclide |
| 04/18/2001 | EP1092028A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
| 04/18/2001 | EP1091742A1 Indium photosensitizers for pdt |
| 04/17/2001 | US6218171 Microbial methods of reducing technetium |
| 04/17/2001 | US6217869 Administering antibody, antigen, ligand complex |
| 04/17/2001 | US6217846 Synthetic peptides for use in thrombus detection |
| 04/17/2001 | US6217844 Methods for detecting lesions in dense breast tissue using LHRH antagonists |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025410A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 04/12/2001 | CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar |
| 04/12/2001 | CA2322936A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive nuclide |
| 04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
| 04/11/2001 | EP1090646A2 Labelled d-mannoheptulose derivatives and their use for imaging of the endocrine pancreas |
| 04/11/2001 | EP1090032A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 04/11/2001 | EP1089966A1 Novel compounds useful in pain management |
| 04/11/2001 | EP1089965A1 Novel compounds |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | EP1089765A2 $i(IN VIVO) DETERMINATION OF METABOLIC FUNCTION FOR USE IN THERAPY MANAGEMENT |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214812 Vitamin b6 bisphosphonate conjugate |
| 04/10/2001 | US6214317 Diagnostic method for diabetes using C-13 labeled pyruvic acid |
| 04/10/2001 | US6214316 Comprising cyclic peptide derivatives; kit for preparing a radiopharmaceutical preparation, comprising a sealed vial containing a predetermined quantity of the peptide |
| 04/10/2001 | US6214315 Radioactive embolizing compositions |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2070647C Use of an anticoagulant as a diagnostic agent |
| 04/05/2001 | WO2001023385A2 Novel tropane analogs |
| 04/05/2001 | WO2000059550A3 Indium-114m and related compositions applicable in brachytherapie |
| 04/05/2001 | WO1995003836B1 Radiolabelled glucans |
| 04/05/2001 | CA2384692A1 Novel tropane analogs |
| 04/04/2001 | CN1290179A Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 04/03/2001 | US6211355 Reacting cobalamin compound with chelating compound to compound useful for in vivo imaging of organs and tumors |
| 04/03/2001 | US6211349 Protonated/acidified nucleic acids and methods of use |
| 04/03/2001 | US6211162 Pulmonary delivery of protonated/acidified nucleic acids |
| 04/03/2001 | US6210703 Glass fiber chemical delivery system |
| 04/03/2001 | US6210653 Administering a sulfonated styrene-maleic anhydride copolymer or a salt thereof with maleic anhydride content 0-95%. |
| 04/03/2001 | US6210313 Radiation therapy method and device |
| 03/29/2001 | WO2001021614A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 03/29/2001 | WO2001021257A1 Radiation source for endovascular radiation treatment in form of a wire |
| 03/29/2001 | WO2001021219A2 Imaging of drug accumulation as a guide to antitumor therapy |
| 03/29/2001 | WO2001021218A2 Method for determining viability of a myocardial segment |
| 03/29/2001 | WO2001021106A1 Radioactive graft or cuff |
| 03/29/2001 | CA2381815A1 Radioactive graft or cuff |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | CN1288755A Pure beta ray corrying safe microball and its preparation |
| 03/28/2001 | CN1063758C Sulphur-35 labeled single clone antibody and its preparing method |
| 03/27/2001 | US6207815 Dna coding for chimeric heavy chain or antigen binding fragment produced by specific cell lines; combines with high molecular weight, tumor-associated sialylated glycoprotein antigen light chain; diagnosis; imaging |
| 03/27/2001 | US6207153 Antigen binding polypeptide |